{
    "id": "783df888-cee2-442a-82ba-094261bf657f",
    "indications": {
        "text": "quinine sulfate capsule usp cinchona alkaloid indicated treatment uncomplicated plasmodium falciparum malaria ( 1 ) .",
        "doid_entities": [
            {
                "text": "plasmodium falciparum malaria (DOID:14067)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_14067"
            },
            {
                "text": "malaria (DOID:12365)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_12365"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "adults ( \u2265 16 years age ) : 648 mg ( two capsules ) every 8 hours 7 days ( 2.1 ) . patients severe chronic renal impairment : one loading dose 648 mg ( two capsules ) followed 12 hours later 324 mg ( one capsule ) every 12 hours 7 days ( 2.2 ) .",
        "doid_entities": [],
        "orphanet_entities": [
            {
                "disease": "severe chronic renal",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_169802"
            }
        ]
    },
    "adverseReactions": "quinine sulfate contraindicated patients following : prolongation qt interval ( 4 ) glucose-6-phosphate dehydrogenase ( g6pd ) deficiency ( 4 ) myasthenia gravis ( 4 ) known hypersensitivity quinine , mefloquine , quinidine ( 4 ) optic neuritis ( 4 )",
    "ingredients": [
        {
            "name": "QUININE SULFATE",
            "code": "KF7Z0E0Q2B",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_52250"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50821"
        },
        {
            "name": "GELATIN",
            "code": "2G86QN327L",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_5291"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "POTASSIUM HYDROXIDE",
            "code": "WZH3C48M4T",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32035"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_16189"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32178"
        }
    ],
    "organization": "Lupin Pharmaceuticals, Inc.",
    "name": "QUININE SULFATE",
    "effectiveTime": "20250130",
    "indications_original": "Quinine sulfate capsule USP is a cinchona alkaloid indicated for treatment of uncomplicated Plasmodium falciparum malaria ( 1 ).",
    "contraindications_original": "Adults (\u2265 16 years of age): 648 mg (two capsules) every 8 hours for 7 days ( 2.1 ). Patients with severe chronic renal impairment: one loading dose of 648 mg (two capsules) followed 12 hours later by 324 mg (one capsule) every 12 hours for 7 days ( 2.2 ).",
    "adverseReactions_original": "Quinine sulfate is contraindicated in patients with the following: Prolongation of QT interval ( 4 ) Glucose-6-phosphate dehydrogenase (G6PD) deficiency ( 4 ) Myasthenia gravis ( 4 ) Known hypersensitivity to quinine, mefloquine, or quinidine ( 4 ) Optic neuritis ( 4 )",
    "drug": [
        {
            "name": "QUININE SULFATE",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_52250"
        }
    ]
}